Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda’s Eohilia to compete Sanofi’s Dupixent in eosinophilic esophagitis treatment
Clinical Trials Arena
Thu, 02/29/24 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
EoE
eosinophilic esophagitis
FDA approves Takeda's therapy for allergic inflammation in esophagus
Reuters
Mon, 02/12/24 - 10:21 am
Takeda
FDA
Eohilia
eosinophilic esophagitis
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another
BioSpace
Fri, 02/9/24 - 11:18 am
Takeda
clinical trials
TAK-861
narcolepsy
Sanofi, Takeda announce CFO changes as part of earnings releases
Medical Marketing and Media
Fri, 02/2/24 - 11:48 am
Sanofi
Takeda
CFOs
earnings
Despite Vyvanse's loss of exclusivity, Takeda treads water thanks to launch momentum
Fierce Pharma
Fri, 02/2/24 - 11:43 am
Takeda
ADHD
Vyvanse
earnings
Takeda grabs late-stage hematology drug from Protagonist
Pharmaphorum
Thu, 02/1/24 - 11:20 am
Takeda
hematology
Protagonist Therapeutics
polycythemia vera
Five years after Shire deal, Takeda looks to reap rewards of latest reinvention
BioPharma Dive
Fri, 01/19/24 - 11:12 am
Takeda
M&A
Shire
fruquintinib
Exkivity
Top 5 Life Science Companies Hiring Remote
BioSpace
Thu, 01/18/24 - 11:12 am
remote work
hirings
Takeda
AbbVie
Moderna Therapeutics
Biomarin
CSL Behring
Takeda Gets FDA Label Expansion for HyQvia in Rare Autoimmune Disorder
BioSpace
Wed, 01/17/24 - 08:27 pm
Takeda
FDA
HyQvia
demyelinating polyneuropathy
JPM 24: How Takeda beat 'almost every biopharmaceutical company' to win Nimbus’ TYK2 med
Fierce Biotech
Thu, 01/11/24 - 11:17 am
Takeda
TAK-279
Nimbus Therapeutics
JPMHC 2024
Drugmakers set to raise US prices on at least 500 drugs in January
Reuters
Tue, 01/2/24 - 09:59 am
drug pricing
Pfizer
Sanofi
Takeda
Takeda’s gene therapy pivot leaves JCR behind after proof-of-concept preclinical test
Fierce Biotech
Thu, 12/21/23 - 09:57 am
Takeda
gene therapy
JCR Pharma
Takeda’s Fruzaqla (Fruquintinib) Gets FDA Nod for Metastatic Colorectal Cancer
Xtalks
Thu, 12/21/23 - 09:42 am
Takeda
FDA
colorectal cancer
fruquintinib
Fruzaqla
Takeda snares approval for all-comer gastric cancer drug
Medical Marketing and Media
Sun, 11/12/23 - 09:23 pm
Takeda
Fruzaqla
colorectal cancer
Takeda Wins First FDA Approval for Ultra-Rare Blood Clotting Disease
BioSpace
Fri, 11/10/23 - 10:12 am
Takeda
FDA
ADAMTS13
Adzynma
cogenital thrombocytopenic purpura
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
BioSpace
Thu, 11/9/23 - 09:48 am
Takeda
fruquintinib
FDA
colorectal cancer
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
earnings
Bristol Myers Squibb
Takeda
Novartis
Sanofi
Merck
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Fierce Pharma
Thu, 10/26/23 - 10:52 pm
Novartis
Takeda
trade secrets
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023
BioSpace
Thu, 10/26/23 - 10:47 pm
Takeda
earnings
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
Thu, 10/19/23 - 10:07 am
Takeda
Crohn's Disease
Alofisel
clinical trials
stem cells
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »